Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodore C Pierson

Showing results (31-40 of 164) with videos related to

Pageof 17
Sort By:
Virology Journal|June 30, 2005
Actively replicating West Nile virus is resistant to cytoplasmic delivery of siRNABrian J Geiss, Theodore C Pierson, Michael S Diamond
Immunological Reviews|October 8, 2008
The structural immunology of antibody protection against West Nile virusMichael S Diamond, Theodore C Pierson, Daved H Fremont
Virus Evolution|November 27, 2025
Constraint in West Nile virus envelope protein across mosquito, human, and avian host cell environmentsJack Dorman, William Bakhache, Theodore C Pierson, et al.
Journal of Virology|September 25, 2009
Protonation of individual histidine residues is not required for the pH-dependent entry of west nile virus: evaluation of the "histidine switch" hypothesisSteevenson Nelson, Subhajit Poddar, Tsai-Yu Lin, et al.
Journal of Virology|August 1, 2014
Combined effects of the structural heterogeneity and dynamics of flaviviruses on antibody recognitionKimberly A Dowd, Swati Mukherjee, Richard J Kuhn, et al.
Virology|August 26, 2004
Determinants within gp120 and gp41 contribute to CD4 independence of SIV EnvsBridget A Puffer, Louis A Altamura, Theodore C Pierson, et al.
Virology|January 15, 2013
Impact of viral attachment factor expression on antibody-mediated neutralization of flavivirusesChristopher J Obara, Kimberly A Dowd, Julie E Ledgerwood, et al.
Cell Host & Microbe|September 10, 2008
Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: implications for vaccine developmentTheodore C Pierson, Daved H Fremont, Richard J Kuhn, et al.
Virology|April 4, 2015
Shake, rattle, and roll: Impact of the dynamics of flavivirus particles on their interactions with the hostRichard J Kuhn, Kimberly A Dowd, Carol Beth Post, et al.
Virology|July 9, 2009
Human antibody titers to Epstein-Barr Virus (EBV) gp350 correlate with neutralization of infectivity better than antibody titers to EBV gp42 using a rapid flow cytometry-based EBV neutralization assayJunji Sashihara, Peter D Burbelo, Barbara Savoldo, et al.
Pageof 17

Showing results (31-40 of 164) with videos related to

Sort By:
Pageof 17
Virology Journal|June 30, 2005
Actively replicating West Nile virus is resistant to cytoplasmic delivery of siRNABrian J Geiss, Theodore C Pierson, Michael S Diamond
Immunological Reviews|October 8, 2008
The structural immunology of antibody protection against West Nile virusMichael S Diamond, Theodore C Pierson, Daved H Fremont
Virus Evolution|November 27, 2025
Constraint in West Nile virus envelope protein across mosquito, human, and avian host cell environmentsJack Dorman, William Bakhache, Theodore C Pierson, et al.
Journal of Virology|September 25, 2009
Protonation of individual histidine residues is not required for the pH-dependent entry of west nile virus: evaluation of the "histidine switch" hypothesisSteevenson Nelson, Subhajit Poddar, Tsai-Yu Lin, et al.
Journal of Virology|August 1, 2014
Combined effects of the structural heterogeneity and dynamics of flaviviruses on antibody recognitionKimberly A Dowd, Swati Mukherjee, Richard J Kuhn, et al.
Virology|August 26, 2004
Determinants within gp120 and gp41 contribute to CD4 independence of SIV EnvsBridget A Puffer, Louis A Altamura, Theodore C Pierson, et al.
Virology|January 15, 2013
Impact of viral attachment factor expression on antibody-mediated neutralization of flavivirusesChristopher J Obara, Kimberly A Dowd, Julie E Ledgerwood, et al.
Cell Host & Microbe|September 10, 2008
Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: implications for vaccine developmentTheodore C Pierson, Daved H Fremont, Richard J Kuhn, et al.
Virology|April 4, 2015
Shake, rattle, and roll: Impact of the dynamics of flavivirus particles on their interactions with the hostRichard J Kuhn, Kimberly A Dowd, Carol Beth Post, et al.
Virology|July 9, 2009
Human antibody titers to Epstein-Barr Virus (EBV) gp350 correlate with neutralization of infectivity better than antibody titers to EBV gp42 using a rapid flow cytometry-based EBV neutralization assayJunji Sashihara, Peter D Burbelo, Barbara Savoldo, et al.
Pageof 17